Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC L2P4 TFA | 98.3% | 1961.83 (free base) | 5 MG
SDP

Catalog No. 5000425225
Encompass_Preferred

L2P4 TFA is a peptide-based and EBNA1 targeting fluorescent probe. It inhibits EBNA1 homodimer formation and selectively inhibits EBV+ tumor growth. L2P4 TFA exhibits cytotoxicity in EBV-positive C666-1 cells with an LC50 of 46.4 μM.

  • Peptide-based probe
  • EBNA1 targeting
  • Inhibits EBNA1 homodimer formation
  • Selectively inhibits EBV+ tumor growth
  • Exhibits cytotoxicity in EBV-positive C666-1 cells
  • Suitable for cancer targeted therapy and immunotherapy research
  • Used in peptide-drug conjugates research

Catalog No. 50-004-25225 Supplier Medchemexpress LLC Supplier No. HYP10772A5MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

L2P4 TFA is a peptide-based and EBNA1 targeting fluorescent probe. It inhibits EBNA1 homodimer formation and selectively inhibits EBV+ tumor growth. L2P4 TFA exhibits cytotoxicity in EBV-positive C666-1 cells with an LC50 of 46.4 μM.

  • Peptide-based probe
  • EBNA1 targeting
  • Inhibits EBNA1 homodimer formation
  • Selectively inhibits EBV+ tumor growth
  • Exhibits cytotoxicity in EBV-positive C666-1 cells
  • Suitable for cancer targeted therapy and immunotherapy research
  • Used in peptide-drug conjugates research

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.